Immunogenicity, Safety and Consistency Of New Trivalent Inactivated Influenza Vaccine

To augment the available influenza vaccine supply, a phase III study was conducted to evaluate the immunogenicity, safety, and consistency of a new trivalent inactivated influenza vaccine manufactured by CSL Limited. Healthy adults (ages 18–64) were randomized to receive either a single dose of TIV...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Talbot, H. Keipp, Keitel, Wendy, Cate, Thomas R., Treanor, John, Campbell, James, Brady, Rebecca C., Graham, Irene, Dekker, Cornelia L., Ho, Dora, Winokur, Patricia, Walter, Emmanuel, Bennet, Jillian, Formica, Neil, Hartel, Gunter, Skeljo, Maryanne, Edwards, Kathryn M.
Format: Artigo
Sprog:Inglês
Udgivet: 2008
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2605420/
https://ncbi.nlm.nih.gov/pubmed/18602726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.05.024
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker